OTC switch in one country should spark "debate" in others -- European assoc. director.
This article was originally published in The Tan Sheet
Executive Summary
OTC SWITCH IN ONE COUNTRY SHOULD SPARK "DEBATE" IN OTHERS, European Proprietary Medicines Manufacturers Association Director Hubertus Cranz asserted during an Oct. 30 session of the World Federation of Proprietary Medicine Manufacturers 12th general assembly in Toronto, Ontario. While a switch in one country "cannot immediately force other countries" to take similar action, it should "stimulate a debate" because it suggests that "comprehensive scientific material" supporting nonprescription status is available, he said.